Argo Biopharma Is Said to Pick Banks for Hong Kong IPO

Chinese biotech firm Argo Biopharmaceutical Co. has picked banks for a Hong Kong initial public offering that could raise a few hundred million dollars, according to people familiar with the...

By Julia Fioretti, Manuel Baigorri · Bloomberg Markets

Chinese biotech firm Argo Biopharmaceutical Co. has picked banks for a Hong Kong initial public offering that could raise a few hundred million dollars, according to people familiar with the matter.